Pulse ·

Blood pressure screening now starts at seven. What Australia just changed.

By Dr HB Lo, FACRRM 4 min read
Verdict Yes — worth knowing about

New Australian guidelines recommend blood pressure screening starting at ages 7–9, with a second check at 13–15. Children with risk factors should be assessed from age 3.

The guidelines diverge from US practice — which advises annual screening from age 3 — because evidence shows accurate, co-operative measurement becomes feasible around age 7. Most children with elevated readings need confirmation and lifestyle review rather than medication. If your child is 7 or older without a recorded BP check, mention it at their next GP visit.

What just happened

Australia now has a dedicated set of clinical guidelines for blood pressure screening in children.

Published in the Journal of Paediatrics and Child Health, the guidelines recommend that all children have their blood pressure checked at ages 7–9, with a second measurement window at 13–15 years. For children at elevated risk — those with family history, chronic conditions, or other factors that increase the probability of early hypertension — screening should start earlier, from age 3.

The guidelines were developed through a national collaboration involving BPOzKids, Hypertension Australia, Murdoch Children’s Research Institute, and Edith Cowan University, drawing on 31 statements adapted from 2017 American paediatric hypertension guidelines.

For anyone familiar with US paediatric practice, the departure from American recommendations is the first thing that stands out. US paediatric guidance advises annual blood pressure screening beginning at age 3 for all children. Australia’s new guidelines set universal screening later and concentrate it across two developmental windows. That’s not a diluted version of the US approach — it’s a clinically reasoned alternative grounded in local evidence and practice realities.

The both-and

Why age 7, not 3?

The guideline developers answer this directly. The recommendation, they write, was based on “studies of blood pressure tracking and clinical experience that children of this age will typically co-operate with the procedure for accurate blood pressure measurement.”

This matters more than it might seem. Blood pressure measurement in a young child is technically demanding. Cuff size must match arm circumference precisely — an incorrect cuff inflates or deflates the reading. Sitting still and arm relaxation are prerequisites for accuracy. Anxiety reliably elevates readings. In children under 6, artefact rates are high enough that many results from single-visit community screening are unreliable without careful technique and multiple readings across visits.

At 7, most children can co-operate with the procedure, understand the instruction, and tolerate the cuff comfortably. The accuracy of screening improves substantially at this age. Screening a restless 3-year-old in a busy general practice and recording an inaccurate number does not create safety — it creates downstream uncertainty that still needs to be resolved.

For at-risk children, the probability calculation changes. A child with a strong family history, significant obesity, or a chronic condition like chronic kidney disease carries enough prior probability of elevated pressure that earlier assessment is worth the additional technical effort. The guidelines hold both positions simultaneously, which is correct screening design.

How common is elevated blood pressure in children?

Rarer than in adults, but not negligible. International estimates suggest elevated blood pressure in approximately 3–5% of children, with true sustained hypertension in around 1–3%. Australian-specific prevalence data is limited, which is itself part of the rationale for formalising a screening schedule — systematic data will accumulate where opportunistic measurement hasn’t.

The longer clinical logic is about tracking. Blood pressure in childhood predicts blood pressure in adulthood: children with elevated pressure are more likely to become adults with hypertension, and the cardiovascular risk from decades of elevated arterial load is not trivially small. A baseline reading in childhood creates a clinical record that informs adult care across a lifetime. That population-level logic is sound even when the individual probability at any single screen is low.

What happens next for children with elevated readings?

For most, the pathway does not involve medication. A single elevated reading requires confirmation: repeat measurements on separate occasions, correct cuff technique confirmed, white-coat effect considered. Most children with initially elevated readings will not have true hypertension on confirmation testing.

When elevated pressure is confirmed, lifestyle review is the first line. Physical activity has a consistent, if modest, antihypertensive effect. Dietary sodium reduction matters for some children. Healthy weight management reduces blood pressure in children with obesity-associated hypertension. These are the primary levers.

Medication is reserved for children with confirmed, persistent hypertension — typically stage 2, or stage 1 with end-organ implications or comorbidities where lifestyle alone is insufficient. The diagnostic bar before initiating antihypertensives in a child is high, as it should be.

My two cents

These guidelines matter most not for the children already being investigated for hypertension — those cases would surface anyway — but for the majority who currently arrive at adulthood with no blood pressure history on record. For a 45-year-old being investigated for a first elevated reading, a childhood baseline would have been genuinely useful context for determining whether this is new or long-standing.

The practical implication for general practice is modest and manageable. When a child aged 7–9 presents for a routine visit — a school medical, an immunisation catch-up, a review of something unrelated — blood pressure measurement fits naturally into the assessment without adding significant consultation time. The 13–15 window aligns with timing many practices associate with adolescent health checks.

For parents asking about the US comparison: the Australian guideline is not less protective. It reflects a different analysis of when accurate measurement is feasible in community settings. Annual screening from age 3 in average-risk children, conducted without specialist equipment and technique, produces many unreliable numbers that require follow-up, generate anxiety, and do not create the safety they appear to create.

Verdict: yes — clear AU guideline change, concrete clinical action for GPs and families.

Sources cited

  1. Start hypertension screening at age seven: new Aussie guidelines. AusDoc, 22 July 2026. https://www.ausdoc.com.au/news/start-hypertension-screening-at-age-seven-new-aussie-guidelines/
  2. Hypertension Australia. https://www.hypertension.com.au
  3. BPOzKids — blood pressure in children. https://www.bpkids.org.au

Frequently asked questions

  • Does my child need a blood pressure check?

    Under the new Australian guidelines, universal screening starts at ages 7–9. If your child is in that range and hasn't had one, it's worth mentioning at a routine GP visit. Children with risk factors — family history of hypertension, obesity, or certain chronic conditions — may benefit from earlier assessment from age 3. Your GP will advise whether your child falls into the at-risk group.

  • What happens if my child's blood pressure is elevated?

    A single elevated reading is not a diagnosis. Blood pressure in children varies with activity, anxiety, and cuff size. Confirmation requires repeat measurements on separate occasions using the correct cuff. Most children with initially elevated readings will not have true hypertension. When elevated pressure is confirmed, lifestyle review — diet, physical activity, healthy weight — is the primary response in most cases, with medication reserved for a smaller group with persistent or severe hypertension.